Literature DB >> 23609317

Haematological cancer: new standard of care?

Rebecca Kirk.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23609317     DOI: 10.1038/nrclinonc.2013.69

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma.

Authors:  Kieron Dunleavy; Stefania Pittaluga; Lauren S Maeda; Ranjana Advani; Clara C Chen; Julie Hessler; Seth M Steinberg; Cliona Grant; George Wright; Gaurav Varma; Louis M Staudt; Elaine S Jaffe; Wyndham H Wilson
Journal:  N Engl J Med       Date:  2013-04-11       Impact factor: 91.245

  1 in total
  1 in total

Review 1.  Current trends in the treatment of primary mediastinal large B-cell lymphoma - an overview.

Authors:  Ivan Petković
Journal:  Contemp Oncol (Pozn)       Date:  2015-12-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.